TLDR:
MEI Pharma sets up $100M Litecoin treasury with major institutional backing.
Litecoin creator Charlie Lee joins MEI Pharma board to lead crypto expansion.
GSR and Titan Partners collaborate to execute LTC treasury strategy.
Move signals Litecoin’s entry into corporate finance and long-term adoption.
MEI Pharma is taking a big step into crypto. The company is building a $100 million Litecoin treasury and bringing in major players to lead it. This move signals a shift as Litecoin gains ground in traditional finance.
At the center of the plan is Litecoin’s creator, Charlie Lee, who’s joining MEI Pharma’s board. The Litecoin Foundation is also backing the strategy with its investment.
Pharma Firm Bets on Litecoin
MEI Pharma is working with Titan Partners Group and GSR, a crypto investment firm, to launch the new treasury. Over $100 million has already been committed, according to the Litecoin Foundation’s announcement. This marks one of the largest institutional moves into Litecoin so far.
Charlie Lee, known for launching Litecoin in 2011, is now taking an active role in guiding MEI Pharma’s crypto expansion. His position on the board ties the project closely to Litecoin’s development.
The Litecoin Foundation also aligned the move with its goal of pushing wider Litecoin adoption.
https://t.co/a4Rr7NfOLH
— Litecoin Foundation 
(@LTCFoundation) July 18, 2025
Lee’s involvement gives the plan more weight. His track record includes pushing Litecoin upgrades like SegWit and opt-in privacy features. These innovations have helped make Litecoin a reliable payment option over the years.
He also played a role in shaping Bitcoin’s growth, having contributed to research labs and other technical improvements. His experience brings strong technical leadership to MEI Pharma’s treasury plan.
Lee said the strategy brings LTC’s utility into an institutional setting, something that hasn’t been done on this scale before.
Litecoin Gains Support from Crypto Investors
Crypto watchers were quick to react. A tweet from Crypto Snorlax called Litecoin one of the best high-liquidity bets in crypto. He pointed to every bull cycle pushing the price above $350. With talk of ETF approvals and market momentum, he said LTC could hit 10x gains
#Litecoin remains the best risk/reward high liquidity widely known crypto.
Every bull cycle $LTC pushes to the $$350+ range.
The chart shows the base case around $450, which is another 4x from here.
If we have ETF approval, mid alt season, this bull cycle.
EXPECT 10x. pic.twitter.com/i2HsXEvRFm
— Crypto Snorlax (@CryptoSnorlax) July 18, 2025
Meanwhile, CoinGecko reports the current Litecoin price is $105.06. The coin is up 3.93% in the last 24 hours and 8.25% for the week.
This $100 million investment shows LTC is gaining trust beyond crypto circles. With strong leadership and institutional interest, it’s not just about price action anymore. MEI Pharma’s bet could open the door for other firms to explore similar strategies.
The project puts LTC in the spotlight again, not just as a payment token, but as a serious asset on corporate balance sheets.
The post MEI Pharma Commits $100M to Litecoin Treasury Strategy: Can LTC Price 10x? appeared first on Blockonomi.
